About Careers MedBlog Contact us

Expert Says Therapy for Acute Stroke Should Be Immediate

by Rajashri on September 26, 2008 at 4:02 PM
Font : A-A+

Expert Says Therapy for Acute Stroke Should Be Immediate

Doctors should not lose a single moment in giving intravenous thrombolysis treatment for acute ischemic stroke, according to a scientist from the UC San Diego Stroke Center.

Patrick Lyden, M.D., professor of neurosciences, has cautioned that that an earlier study on the efficacy of the treatment after acute stroke should not be interpreted to mean that such therapy can be withheld for hours or even minutes.


"The risk of withholding such treatment from patients with acute stroke greatly exceeds the risk of giving it. The potential for reversing the disabling side effects of stroke declines with every passing minute," said Lyden. "."

Lyden's warning comes in line with the study, ("Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke") by Werner Hacke, M.D. et al, that reported the findings from the European Cooperative Acute Stroke Study III (ECASS III).

The design of this study was quite similar to that of the original National Institute of Neurological Disorders and Stroke (NINDS) trial of recombinant tissue plasminogen activator (rt-PA) for acute stroke. It was a pivotal trial that Lyden helped lead that showed the first proven therapy for stroke.

The important exception in the ECASS III trial is that the window of therapy was expanded to a period of three to four and a half hours, compared to under three hours in the NINDS trial.

Lydens aid that the biggest drawback of the BCASS III data is that some may take a slower approach to treating acute stroke.

"Nothing could be more wrong. As we look back on the past decade of thrombolytic therapy for stroke, it is very clear that our focus must remain on the door-to-needle time. Every minute matters during a stroke," said Lyden.

Source: ANI


Recommended Reading

Latest Heart Disease News

Delay in Seeking Care Results in 55% of Cardiac Deaths in India
The first community-based study, published in the journal Lancet, says that delays in seeking care account for nearly 55% of the reported cardiac and stroke deaths in India.
The Surprising Impact of Quit Smoking: 36% Lower Cardiovascular Risk
The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.
 Discovering Genetic Risks for Type of Heart Attack Largely Affecting Younger Women
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
Unlocking the Crystal Ball: Heart Failure Subtypes Helps Forecast Future Risks!
Recent study identifies five heart failure subtypes with the potential for individual patient risk prediction.
Is CT Scan the Best Way to Predict Heart Disease Risk?
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Expert Says Therapy for Acute Stroke Should Be Immediate Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests